Categories

País suma 2.555 casos COVID-19 el miércoles, 2.559 el jueves, 2.392 el viernes, 2.029 el sábado, 2.463 el domingo, 1.500 el lunes y 2.236 hoy martes: 273.714 casos COVID-19 totales

País suma 2.555 casos COVID-19 el miércoles, 2.559 el jueves, 2.392 el viernes, 2.029 el sábado, 2.463 el domingo, 1.500 el lunes y 2.236 hoy martes: 273.714 casos COVID-19 totales

País suma 2.555 casos COVID-19 el miércoles, 2.559 el jueves, 2.392 el viernes, 2.029 el sábado, 2.463 el domingo, 1.500 el lunes y 2.236 hoy martes: 273.714 casos COVID-19 totalesMartes 11 de mayo, 2021. El país registró 2.555 casos nuevos de COVID-19 el miércoles 05 de mayo, 2.559 el jueves 06 de mayo, 2.392...

https://www.ministeriodesalud.go.cr/index.php/centro-de-prensa/noticias/746-noticias-2021/2095-pais-suma-2-555-casos-covid-19-el-miercoles-2-559-el-jueves-2-392-el-viernes-2-029-el-sabado-2-463-el-domingo-1-500-el-lunes-y-2-236-hoy-martes-273-714-casos-covid-19-totales

 
Categories

FDA In Brief: FDA Finalizes Guidance with Internationally Harmonized Recommendations to Further Support Safe, High-Quality Human Drug Products

FDA In Brief: FDA Finalizes Guidance with Internationally Harmonized Recommendations to Further Support Safe, High-Quality Human Drug Products
http://www.fda.gov/news-events/press-announcements/fda-brief-fda-finalizes-guidance-internationally-harmonized-recommendations-further-support-safe

 
Categories

Yamtun7 Issues Voluntary Nationwide Recall of Poseidon Platinum 3500 Due to the Presence of Undeclared Tadalafil and Sildenafil

Delray Beach, Florida, Yamtun7 is voluntarily recalling all lots of Poseidon Platinum 3500 to the consumer level. FDA analysis has found the product to contain undeclared tadalafil and sildenafil. Tadalafil and sildenafil are drugs known as phosphodiesterase (PDE-5) inhibitors found in FDA approved

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/yamtun7-issues-voluntary-nationwide-recall-poseidon-platinum-3500-due-presence-undeclared-tadalafil

 
Categories

Coronavirus (COVID-19) Update: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Adolescents in Another Important Action in Fight Against Pandemic

Coronavirus (COVID-19) Update: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Adolescents in Another Important Action in Fight Against Pandemic
http://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use

 
Categories

FDA In Brief: FDA to Hold Meeting of its Vaccines and Related Biological Products Advisory Committee to Discuss Pediatric Use of COVID-19 Vaccines

FDA In Brief: FDA to Hold Meeting of its Vaccines and Related Biological Products Advisory Committee to Discuss Pediatric Use of COVID-19 Vaccines
http://www.fda.gov/news-events/press-announcements/fda-brief-fda-hold-meeting-its-vaccines-and-related-biological-products-advisory-committee-discuss

 
Categories

Novo Nordisk Issues Voluntary Nationwide Recall of Levemir®, Tresiba®, Fiasp®, Novolog® and Xultophy® Product Samples Due to Improper Storage Temperature Conditions

Novo Nordisk is voluntarily recalling 1,468 product samples listed in the table below of Levemir®, Tresiba®, Fiasp®, Novolog® and Xultophy®, to the consumer level. These products are being recalled because they were stored at temperatures below storage requirements. This recall only impacts product

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/novo-nordisk-issues-voluntary-nationwide-recall-levemirr-tresibar-fiaspr-novologr-and-xultophyr